Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.